吉林大学学报(医学版) ›› 2017, Vol. 43 ›› Issue (01): 73-79.doi: 10.13481/j.1671-587x.20170115

• 临床研究 • 上一篇    下一篇

雄激素受体对三阴性乳腺癌患者生存状况影响的Meta分析

张成帅1, 潘翠柳2, 高亚男2, 韩冰2, 张志茹2, 李峰1   

  1. 1. 吉林大学护理学院外科教研室, 吉林 长春 130021;
    2. 吉林大学第一医院乳腺外科, 吉林 长春 130021
  • 收稿日期:2016-06-28 出版日期:2017-01-28 发布日期:2017-02-08
  • 通讯作者: 张志茹,副主任护师(Tel:0431-85619545,E-mail:zhangcs14@mails.jlu.edu.cn);李峰,教授,博士研究生导师(Tel:0431-88785661,E-mail:fli@jlu.edu.cn) E-mail:zhangcs14@mails.jlu.edu.cn;fli@jlu.edu.cn
  • 作者简介:张成帅(1991-),男,山东省淄博市人,在读护理学硕士,主要从事肿瘤护理学方面的研究。
  • 基金资助:

    吉林省科技厅科技发展计划项目资助课题(20150101205jc)

Meta-analysis on influence of androgen receptor in living conditions of patients with triple-negative breast cancer

ZHANG Chengshuai1, PAN Cuiliu2, GAO Yanan2, HAN Bing2, ZHANG Zhiru2, LI Feng1   

  1. 1. Department of Surgery, Schoolof Nursing, Jilin University, Changchun 130021, China;
    2. Department of Breast Surgery, First Hospital, Jilin University, Changchun 130021, China
  • Received:2016-06-28 Online:2017-01-28 Published:2017-02-08

摘要:

目的:系统评价雄激素受体(AR)对三阴性乳腺癌患者生存状况的影响,探讨AR阳性和阴性乳腺癌患者生存率的差异。方法:计算机检索PubMed、Medline、EMbase、Cochrane Library、中国生物医学文献服务系统(CBM)、中国期刊全文数据库(CNKI)、万方数据库和维普数据库中关于AR对三阴性乳腺癌患者生存状况影响的相关研究,采用RevMan 5.1软件进行Meta分析。结果:最终纳入文献9篇,其中英文文献5篇,中文文献4篇,均为队列研究。研究对象1295例,其中AR阴性患者933例,阳性患者362例。文献质量评价,7篇文献得分>7分,2篇文献<7分。合并效应量结果,三阴性乳腺癌AR阳性和阴性患者无病生存率(DFS)和总生存率(OS)比较差异无统计学意义(OR=0.70,95% CI:0.33~1.46,P=0.32;OR=0.41,95% CI:0.17~0.98,P=0.05),AR阳性患者5年DFS和OS明显高于AR阴性患者(OR=0.30,95% CI:0.11~0.86,P=0.02;OR=0.19,95% CI:0.11~0.33,P<0.01)。结论:AR对三阴性乳腺癌患者5年DFS和OS存在积极影响,但尚不能证实其对三阴性乳腺癌患者3年或10年生存率的影响作用。

关键词: 三阴性乳腺癌, 雄激素受体, 系统评价, 无病生存率, 总生存率

Abstract:

Objective: To evaluate the influence of androgen receptor(AR) in the living conditions in the triple-negative breast cancer patients,and to explore whether there is a difference in the survival rates between the breast cancer patients with positive AR and those with negative AR.Methods: PubMed,Medline,EMbase,Cochrane Library,CNKI,CBM,Wanfang,and VIP databases were systemically searched to collect the published studies about the influence of AR in the living conditions of the patients with triple-negative breast cancer. Meta-analysis was performed by RevMan 5.1 software.Results: There were 9 cohort studies were selected for Meta-analysis,4 Chinese and 5 English.1 295 patients included 362 AR+ and 933 AR-.In evaluation of study quality,7 studies scored more than 7,and 2 studies less than 6.The overall survival(OS) and disease-free survival (DFS) of the triple-negative breast cancer patients with AR+ and AR- had no differences (OR=0.70,95%CI:0.33-1.46,P=0.32;OR=0.41,95%CI:0.17-0.98,P=0.05). The 5-year DFS and OS of the AR+ patients were higher than the AR-patients(OR=0.30,95%CI:0.11-0.86,P=0.02;OR=0.19,95%CI:0.11-0.33,P<0.01).Conclusion: AR has a positive impact on the 5-year DFS and OS of the triple-negative breast cancer patients,but its influence in the 3-year and 10-year survival can't be confirmed.

Key words: triple-negative breast cancer, estrogen receptor, Meta-analysis, disease-free survival, overall survival

中图分类号: 

  • R737.9